Jeffrey A Bell

7PUBLICATIONS
25CO-AUTHORS
Gene and molecular therapyCheminformatics and quantitative structure-activity relationshipsComputational chemistryBiomolecular modelling and designMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 13, 2025
Accelerated In Silico Discovery of SGR-1505: A Potent MALT1 Allosteric Inhibitor for the Treatment of Mature B-Cell Malignancies.

Zhe Nie, Michael Trzoss, Andrew T Placzek

|Oct 12, 2025
Discovery of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 Main Protease through Computer-Aided Drug Design.

Atsutoshi Okabe, Daniel W Carney, Michiko Tawada

|Aug 26, 2025
Harnessing free energy calculations for kinome-wide selectivity in drug discovery campaigns with a Wee1 case study.

Jennifer Lynn Knight, Anthony J Clark, Jiashi Wang

|Mar 19, 2025
Exploiting Solvent Exposed Salt-Bridge Interactions for the Discovery of Potent Inhibitors of SOS1 Using Free-Energy Perturbation Simulations.

Abba E Leffler, Evelyne M Houang, Felicia Gray

|Dec 13, 2024
In Silico Enabled Discovery of KAI-11101, a Preclinical DLK Inhibitor for the Treatment of Neurodegenerative Disease and Neuronal Injury.

H Rachel Lagiakos, Yefen Zou, Hideyuki Igawa

|Dec 12, 2024
Discovery of a Novel Mutant-Selective Epidermal Growth Factor Receptor Inhibitor Using an In Silico Enabled Drug Discovery Platform.

Hideyuki Igawa, Zef A Konst, Eric Therrien

Pageof 2

Frequent Collaborators

3 joint publications

Hideyuki Igawa

3 joint publications

Robert D Pelletier

2 joint publications

Sathesh Bhat

2 joint publications

Abba E Leffler